Solid Biosciences proposes $100M IPO

Solid Biosciences LLC (Cambridge, Mass.) is seeking to raise up to $100 million in an IPO on NASDAQ, according to an SEC document filed Dec. 29, 2017. JPMorgan, Goldman Sachs, Leerink, Nomura and Chardan are underwriting the offering...